Common Equity: The sum of all common equity items.
Emergent Biosolutions Inc. (EBS) had Common Equity of $482.80M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.04B |
|
$-190.60M |
|
$681.30M |
|
$362.30M |
|
$1.15B |
|
$-108.70M |
|
$-34.20M |
|
$-142.90M |
|
$-142.90M |
|
$-190.60M |
|
$-190.60M |
|
$-190.60M |
|
$-190.60M |
|
$-108.70M |
|
$7.50M |
|
53.00M |
|
53.00M |
|
$-3.60 |
|
$-3.60 |
|
| Balance Sheet Financials | |
$598.70M |
|
$270.60M |
|
$791.00M |
|
$1.39B |
|
$162.40M |
|
$663.70M |
|
$744.50M |
|
$906.90M |
|
|
Common Equity |
$482.80M |
$-18.70M |
|
$482.80M |
|
54.30M |
|
| Cash Flow Statement Financials | |
$58.70M |
|
$125.20M |
|
$-190.00M |
|
$111.70M |
|
$105.60M |
|
$-6.10M |
|
$18.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.69 |
|
-- |
|
-- |
|
0.58 |
|
1.37 |
|
34.72% |
|
-10.42% |
|
-10.42% |
|
0.72% |
|
-13.69% |
|
-18.26% |
|
$43.70M |
|
-- |
|
-- |
|
-- |
|
0.75 |
|
2.19 |
|
6.75 |
|
54.04 |
|
-39.48% |
|
1019.25% |
|
-13.72% |
|
-16.62% |
|
$8.89 |
|
$0.82 |
|
$1.11 |
|